Dyadic International (DYAI) to Release Earnings on Wednesday

Dyadic International (NASDAQ:DYAI) will likely be posting its quarterly earnings results before the market opens on Wednesday, March 26th. Analysts expect Dyadic International to post earnings of ($0.04) per share and revenue of $1.60 million for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Dyadic International Stock Performance

Shares of NASDAQ:DYAI opened at $1.38 on Wednesday. The company has a market capitalization of $40.83 million, a price-to-earnings ratio of -6.00 and a beta of 0.95. Dyadic International has a 52 week low of $0.93 and a 52 week high of $2.67. The company has a quick ratio of 5.15, a current ratio of 5.15 and a debt-to-equity ratio of 1.54. The firm has a 50 day moving average of $1.51 and a 200 day moving average of $1.42.

Hedge Funds Weigh In On Dyadic International

An institutional investor recently raised its position in Dyadic International stock. Bank of America Corp DE raised its holdings in Dyadic International, Inc. (NASDAQ:DYAI) by 16,146.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 27,132 shares of the biotechnology company’s stock after purchasing an additional 26,965 shares during the quarter. Bank of America Corp DE owned 0.09% of Dyadic International worth $47,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 27.95% of the company’s stock.

About Dyadic International

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.